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Abstract Understanding process parameter interactions
and their effects on mammalian cell cultivations is an
essential requirement for robust process scale-up. Further-
more, knowledge of the relationship between the process
parameters and the product critical quality attributes
(CQAs) is necessary to satisfy quality by design guidelines.
So far, mainly the effect of single parameters on CQAs was
investigated. Here, we present a comprehensive study to
investigate the interactions of scale-up relevant parameters
as pH, pO2 and pCO2 on CHO cell physiology, process
performance and CQAs, which was based on design of
experiments and extended product quality analytics. The
study used a novel control strategy in which process
parameters were decoupled from each other, and thus
allowed their individual control at defined set points.
Besides having identified the impact of single parameters
on process performance and product quality, further sig-
nificant interaction effects of process parameters on
specific cell growth, specific productivity and amino acid
metabolism could be derived using this method. Concern-
ing single parameter effects, several monoclonal antibody
(mAb) charge variants were affected by process pCO2 and
pH. N-glycosylation analysis showed positive correlations
between mAb sialylation and high pH values as well as a
relationship between high mannose variants and process
pH. This study additionally revealed several interaction
effects as process pH and pCO2 interactions on mAb
charge variants and N-glycosylation pattern. Hence,
through our process control strategy and multivariate
investigation, novel significant process parameter interac-
tions and single effects were identified which have to be
taken into account especially for process scale-up.
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Introduction
Monoclonal antibodies (mAbs) have become the main
products of biopharmaceutical industries throughout the
past decades. Despite their typically low growth rate,
unstable productivity and high process costs, mammalian
cells benefit from their ability to perform human-like
posttranslational modifications and thus represent the main
expression system for mAb production [1–3]. Chinese
hamster ovary (CHO) cells are the most commonly used
cell systems for mammalian processes. Since GMP cer-
tificated processes are readily available and high through-
put cell screening and fed-batch processing are established
and well understood CHO cells will remain the main
expression system in the near future [3–5]. Advanced
understanding of CHO cell metabolism and interaction
with process parameters is of high importance for process
optimization, scale-up; and moreover, is a major require-
ment of quality by design (QbD) guidelines as claimed by
the Federal Drug Association (FDA) [6]. Furthermore,
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modeling approaches as hybrid models may benefit from
the knowledge of process parameter interactions and single
effects to improve model fit and model quality [7].
Understanding of process parameter interactions is espe-
cially useful during process scale-up, where unwanted
variations of pH, dissolved oxygen tension (pO2) and car-
bon dioxide tension (pCO2) are most likely to occur [8–10].
Manufacturing processes aim towards high product titers
and space–time-yields but, moreover, good and consistent
final product quality is of upmost importance. Monoclonal
antibodies are very complex molecules and can be modi-
fied during up- and downstream process thus leading to
heterogeneous final products [11]. Product heterogeneity
may lead to various changes in physiochemical, biological
and immunogenic properties compared to the desired
homogeneous antibody drug. In more detail, protein
heterogeneity may lead to different protein binding, sta-
bility, immune responses and pharmacokinetics [12].
Therefore, control of product heterogeneity within prede-
fined analytical specifications is of high importance for
cGMP manufacturing.
Process parameters such as temperature, pH, pO2 and
pCO2 can have enormous effects on CHO cell process
performance and critical quality attributes as described
widely in the literature [13–17]. Link et al. [15] discovered
that changing dissolved oxygen concentration can have an
effect on specific productivity of CHO-K1 cells. Addi-
tionally, a study conducted by Trummer et al. [13] showed
significant influences of culture temperature and culture pH
on cell metabolism, growth and product quality in a CHO
batch fermentation producing EPO-Fc. However, influ-
ences of different carbon dioxide tensions are most often
neglected although it has been shown in other studies that
pCO2 can have significant effects on specific cell growth,
productivity and product quality [18–20]. Studies about
interaction effects of parameters are less prominent in the
literature, however, Zanghi et al. [19] showed that at ele-
vated pH or pCO2 in a CHO culture, osmolality and
bicarbonate concentration significantly influence product
polysialylation.
In contrast to the current state of the art, the goal of our
study was to derive interaction effects of critical scale-up
parameters on cell physiology as well as on process per-
formance and critical product quality attributes. Therefore,
our approach consisted of a central composite face-cen-
tered design of experiments and various in-process ana-
lytics as well as product quality analytics for charge, size
and glycan heterogeneity. This investigation was only
possible through usage of a novel control strategy via
decoupling of pO2, pH and pCO2 process control and thus
investigating the individual effects and interactions of these
critical scale-up parameters in one systematic approach.
The novelty of this work is therefore the elucidation of
interaction effects of scale dependent process parameters
on a large number of responses including amino acids and
product quality attributes.
Materials and methods
Design of experiment and data evaluation
Experiments were carried out according to a central com-
posite face-centered design with the factors pH ranging
from 6.8 to 7.2, pO2 from 10 to 40 % and pCO2 from 5
(37 mmHg) to 20 % (150 mmHg) (Table 1). Boundaries
were set for pCO2 in between physiological values and
levels that might occur during large-scale fermentation
processes [9], whereas pH was mostly set in between
boundaries of physiological ranges to allow constant fer-
mentation conditions. However, pH variations to 6.8 may
also occur during large-scale fermentation due to CO2
gradients [21]. The dissolved oxygen tension concentration
upper limit was set to 40 % according to common indus-
trial settings. Since in large-scale fermentations at high cell
densities pO2 gradients are likely to occur [9], the lower
limit for pO2 was set to 10 %. In total, the experimental
design space consisted of 19 batch fermentations, whereas
five fermentation runs were carried out at the center point
settings of the DoE. Due to problems with one of the pH-
probes, one fermentation run at pH 7.2, pO2 40 % and
pCO2 20 % finally had to be excluded from data evalua-
tion. Since all other 14 set points of the experimental
design space were carried out successfully, this one miss-
ing run was found not to compromise the quality of the
experimental design to any significant extent. Furthermore,
two fermentation runs (pH 7; pCO2 20 %; pO2 25 % and
pH 7; pCO2 12.5 %; pO2 10 %) revealed unusually high
mAb aggregation rates and thus their mAb quality data
were excluded from data evaluation.
Experimental planning and data evaluation was carried
out by the help of the software MODDE (Umetrics,
Sweden). For each selected response MODDE generates a
PLS Model and the final parameters after model opti-
mization are illustrated in this report. Key parameters of
the models are the coefficient of determination R2, good-
ness of prediction Q2, model validity MV and repro-
ducibility RP. Ideally, R2, Q2, MV and RP should be close
to 1 and above 0.5, or 0.25 concerning MV, for a signifi-
cant model. Furthermore, tables with normalized coeffi-
cients derived out of PLS models are shown in this work.
Since errors for specific growth and metabolite produc-
tion/consumption rates are generally high in mammalian
processes [22], confidence intervals were set to 0.90 for all
calculated growth, consumption and production rates. For
all other responses, confidence levels were set to 0.95. The
252 Bioprocess Biosyst Eng (2017) 40:251–263
123
responses analyzed were maximum and average specific
growth rate (lmax, laverage), specific lactate and ammonia
production (qlac, qamm), specific glucose and glutamine
consumption (qgluc, qgln), further specific amino acid con-
sumption and production rates (qAla, qArg, qAsn, qAsp, qCys,
qGlu, qGly, qHis, qIle, qLeu, qLys, qMeth, qPhe, qPro, qSer, qThr,
qTyr, qTry, qVal) and specific productivity (qp). Moreover,
critical product quality attributes were analyzed as charge,
size and glycan variants.
Cell line, seed train and batch fermentations
An industrial CHO cell line producing a mAb was cultivated
in chemically defined media. Precultures for batch fermen-
tation processes were cultivated in shake flasks and incu-
bated at 10 % pCO2 and 37 C temperature. Exponentially
growing cells were transferred into 3 L glass bioreactors
resulting in an inoculation density of 3 9 105 cells/mL. All
batch cultivations were carried out at 37 C.
Using a novel control strategy, pO2, pCO2 and pH set
points were set and kept constant throughout the fermen-
tation process according to the DoE. Usually, pH control in
cell culture is performed using pCO2 as acid; this had to be
changed to decouple pH and pCO2 control. pH regulation
was therefore realized by the addition of 0.5 M HCL and
0.5 M NaOH, respectively. Dissolved oxygen tension and
carbon dioxide tension were regulated independently
through gas mixing while keeping stirrer speed and gas
volumetric flow rate constant. pCO2 measurement and
control was done by use of an off-gas sensor (BlueInOne,
Bluesens, Germany) and based on calculations from Frahm
et al. [23]. pH and pO2 were measured by in-line probes
(EasyFerm, Hamilton, United States and VisiFerm,
Hamilton, United States).
In-process control, mAb and amino acid
determination
Cultivation samples were taken every 12 h and cell count-
ing/viability determination was performed using the auto-
matic picture analyzer Cedex HiRes Analyzer (Roche,
Germany). Osmolality of supernatant was determined via
freeze point depression (Mikro-Osmometer TypOM806,
Lo¨ser, Germany). Analysis of metabolites glucose, glu-
tamine, glutamate, lactate and ammonium were performed
using Cedex Bio HT Analyzer (Roche, Germany). Antibody
titer determination was carried out by HPLC (Ultimate
3000, Dionex, United States) with a Protein A sensor car-
tridge (Applied Biosystems, The Netherlands). Amino acid
concentrations were determined by HPLC measurement
(Ultimate 3000, Dionex, United States; ZORBAX Eclipse
Plus C18 column, Agilent Technologies, United States) and
prior sample-derivatization with ortho-phthalaldehyde
(OPA) and 9-fluorenylmethyloxycarbonyl (FMOC).
Product quality analytics
Harvest samples for product quality analytics were taken
only once at the end of batch processes as soon as viability
dropped below 75 % and supernatants were stored at
-80 C.
Cation exchange chromatography
Determination of charge variants was performed using a
ProPac WCX-10 (4 9 250 mm) analytical column (Dio-
nex, United States) connected to HPLC system (Agilent
Technologies 1100/1200 Series, United States) with UV
detection at 220 nm.
Size exclusion chromatography
Size exclusion chromatography was performed using a
TSKgel G3000SWXL column (Tosoh, Japan) connected to
a HPLC system (Agilent Technologies 1100/1200 Series,
United States) with UV detection at 210 nm.
N-glycan determination
Quantitative determination of N-glycans was performed
after digest with N-glycosidase F (PNGase F, Roche,
Germany). After separation from the protein using ultra
Table 1 Specific process
parameter conditions of the
experimental design space
Exp. No. 1 2 3 4 5 6 7 8 9 10
pH 6.8 7.2 6.8 7.2 6.8 7.2 6.8 7.2 7 7
pCO2 5 5 20 20 5 5 20 20 12.5 12.5
pO2 10 10 10 10 40 40 40 40 25 25
Exp. No. 11 12 13 14 15 16 17 18 19
pH 7 7.2 6.8 7 7 7 7 7 7
pCO2 12.5 12.5 12.5 5 20 12.5 12.5 12.5 12.5
pO2 25 25 25 25 25 10 40 25 25
Experiment number 8 had to be excluded from data evaluation due to a defect pH probe
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centrifugal filters, released N-glycans were labeled with
2-aminobenzamide (2-AB) at 37 C overnight. Afterwards
2-AB labeled glycans were profiled by normal phase
chromatography using a ACQUITY UPLC BEH column
(Waters, United States) connected to an HPLC system
(Agilent 1200 series, United States) with FLD detection.
Calculation of specific rates and degree
of glycosylation
Calculation of the specific growth rate l was performed
using the integral of viable cell density as described by
Klein et al. [24] and shown in Eq. (1):
l ¼ dðVCDÞ
d(IVCD)
; ð1Þ
with VCD being the viable cell density and IVCD the
integral of viable cell density.
Calculation of the specific production or consumption
rates was performed as shown in Eq. (2), with ci being the
concentration of either a specific metabolite or product i:
qi ¼ dðciÞ
d(IVCDÞ : ð2Þ
Calculation of the specific growth and production or
consumption rates were performed for each time point and
average rates were calculated for the relevant process phase
using values between inoculation and peak VCD. The
maximum specific growth rate, however, was calculated
only for time points within the exponential growth phase of
the processes. All cell specific metabolic rates were
assigned positive for production and negative for
consumption.
The degree of galactosylation (GI) was calculated as
shown in Eq. (3) and described earlier by Ivarsson et al.
[17]:
GI ¼ 3 G3þ 2 G2þ G1ðG0þ G1þ G2þ G3Þ  3 : ð3Þ
The degrees of sialylation (SI) and afucosylation (aFI)
were calculated in the same manner.
Results and discussion
Experiments were carried out according to our experi-
mental design as specified in the ‘‘Materials and methods’’
section. The specific data points for the PLS models are
summarized in the supplementary file. Concerning the
evaluation of the data, additionally to our controlled pro-
cess parameters, the influences of important uncontrolled
parameters on the responses of the design of experiments
were considered. Especially effects that might occur due to
different osmolalities, average cell viabilities and overall
process time.
Although only minor variations in osmolality occurred
during cell growth (mostly between 290 and 330 mOsm/
kg), the influence of variations in osmolality was investi-
gated in separate experiments and no significant differ-
ences in cell specific growth, productivity or metabolite
production/consumption could be derived for this cell line
(data not shown).
The overall batch process time and mean cell viabilities
in this study correlate strongly with process pH but not
with pO2 and pCO2 (Fig. 1). Therefore, effects on product
quality data attributed to process pH might furthermore
derive from different process times or mean cell viabilities.
Effects of pCO2 and pO2 were found to be independent
from process time. The authors would like to state that due
to the complexity of mammalian cell culture processes,
only a certain portion of the data variability can be
explained by the presented models. Therefore, the good-
ness of fit R2, a measure how good the model fits the
observed data, and the goodness of prediction Q2, an
estimate of the predictive ability of the model, deviate from
the ideal value of 1. However, R2 and Q2 values are pre-
sented in the corresponding data tables and only significant
models with values above 0.5 are discussed.
Effects on cell growth and viability
Cell growth and cell viability are essential parameters that
have to be monitored closely during mammalian fermen-
tation processes. This is usually done by automated offline
cell counting and live/dead cell staining. Through deter-
mination of viable and total cell densities (VCD and TCD)
specific cell growth and cell viabilities were evaluated.
Comparing the maximum viable cell density (VCD) of
all batch processes, it can be derived that processes at pH
7.0 reached the highest maximum viable cell densities
(Fig. 1a). All processes declined in viabilities to values
lower than 75 % shortly after limitation of the main
C-source. Therefore, differences in maximum VCD
derived not only from different growth behavior but fur-
thermore from nutrient availability. Cell viabilities stayed
at high values and decreased dramatically as soon as glu-
cose became limiting. Furthermore, slight decreases in cell
viabilities could be detected for processes at pH 7.0 and
6.8, most probably due to glutamine limitation before final
glucose depletion (Figs. 1b, 2a/b).
Regarding specific cell growth during exponential
growth (lmax) and total growth phase (laverage) significant
influences of pH, pO2 and pCO2 as well as a significant
interaction of pH and pCO2 could be detected (Table 2).
lmax and laverage were strongly affected by process con-
ditions, whereby the lowest growth rates were reduced to
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around 35 and 45 %, respectively, when compared to the
maximum values obtained in this DoE.
Table 2 shows that pH affected specific cell growth the
most and higher pH values led to higher cell growth.
Increased pCO2 had a negative impact on cell growth,
whereas increased pO2 seemed to stimulate specific cell
growth between the borders of our experimental design.
These general results confirm other publications as Link
et al. [15], Yoon et al. [25], Trummer et al. [13] and
Dezengotita et al. [18]. Remarkably, through the indepen-
dent control of process parameters our study derived
additional significant interaction effects of pH and pCO2 on
specific growth.
Effects on cell metabolism and productivity
CHO cell metabolism strongly depends on the main carbon
and energy sources, glucose and glutamine. Furthermore,
by-product accumulation can be of high interest since
lactate and ammonia concentrations can affect cell
physiology at elevated levels [26]. Moreover, specific
productivity of cells is clearly of high importance, because
final product titer levels are directly correlated with this
entity. Additionally, amino acids are one of the most
important cell culture media components, influencing cell
growth and productivity [27].
In Table 2 the result for the DoE evaluation regarding
the average specific glucose uptake rate qgluc is shown.
qgluc was significantly influenced by process pH whereby
lowest rates were reduced to around 60 % when compared
to the maximum consumption rates obtained in this DoE.
No significant pO2, pCO2 or quadratic/interaction terms
could be determined. These results can be confirmed by
other studies [13, 25, 26].
The mean specific glutamine uptake rate was not sig-
nificantly influenced by pH or pCO2 or pO2 (data not
shown). Concerning pH this is in accordance to the results
from Yoon et al. [25] but contrary to Trummer et al. [13]
who observed higher specific consumption rates at higher
pH values. Processes at high pH values depleted earlier of
glutamine than processes at low pH (Fig. 2). Since no
effects on specific glutamine uptake rates could be deter-
mined, this effect is most probably due to higher viable cell
densities and thus higher total glutamine consumptions at
high pH values.
The average specific lactate production rate qlac was
significantly affected by process conditions (Table 1),
whereby lowest rates were reduced to around 80 % when
compared to the maximum production rates obtained in
this study. Comparing the specific lactate production qlac
during the growth phase, data clearly shows a direct link
between pH and lactate production. Runs at highest pH
values produced significantly more lactate than cells at
lower pH. This effect is well reported in literature [13].
Furthermore, the yield of glucose to lactate was affected
by culture pH, higher pH values leading to higher yields.
Dependencies of qlac from pO2 or pCO2 could not be
found.
No significant effects of either pH, pCO2 or pO2 on
specific ammonia production could be observed (data not
shown). This is in agreement with the results from Yoon
et al. [25] but contrary to Trummer et al. [13], who found a
dependency of specific ammonia production from culture
pH. The contrary findings on specific ammonia production
and glutamine consumption in the stated literature may
indicate that effects on ammonia and glutamine metabo-
lism are more cell line specific than effects on glucose and
lactate metabolism.
Due to higher specific glucose consumption rates and
higher cell growth, processes became glucose-limited ear-
liest at pH 7.2 (Fig. 2a). Ammonia profiles varied between
phases of ammonia production and consumption through-
out most processes at 7.0 (Fig. 2c). All fermentation runs at
Fig. 1 Viable cell density (a) and cell viability (b) over process time
for all batch fermentations. (Black symbols represent processes at pH
7.0, blue symbols at pH 6.8, red symbols at pH 7.2; closed symbols
represent processes at pCO2 5 %, half-closed at 12.5 % and open
symbols at 20 %; triangles represent processes at pO2 25 %, squares
at 10 %, circles at 40 %). High pH values led to high viable cell
densities but concurrently to shorter process time due to faster
depletion of the main c-source. Cell viabilities stayed at high values
as long as glutamine was available
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pH 6.8 showed no significant ammonia consumption over
process time and thus resulted in general higher final
ammonia concentrations. Similar to Li et al. [28] low levels
of lactate during the lactate consumption phase, present at
most processes at pH 7.0 and 6.8, led to the consumption of
alanine (data not shown) and subsequently to an increase in
final ammonia levels.
Additionally to glutamine, 19 other amino acids were
analyzed by HPLC. Specific consumption or production
rates were calculated during the growth phase and
Fig. 2 Metabolite profiles for all conducted batch processes. (Black
symbols represent processes at pH 7.0, blue symbols at pH 6.8, red
symbols at pH 7.2; closed symbols represent processes at pCO2 5 %,
half-closed at 12.5 % and open symbols at 20 %; triangles represent
processes at pO2 25 %, squares at 10 %, circles at 40 %). a Glucose
became limiting in almost all fermentations before reaching the
harvest criteria of 75 % viability. b Glutamine profiles showed
glutamine limitations after 100–150 h of process time for all batches.
c Ammonia concentrations showed process phases of production and
consumption for almost all runs at pH values of 6.8 and 7.0, whereas
only production and steady-state values were derived from fermen-
tation runs at pH 6.8. d Lactate was produced and consumed during
all processes
Table 2 Coefficient table and
summary of fit of the models
obtained for specific growth
rates, specific glucose
consumption, specific lactate
and IgG production rates
pH pO2 pCO2 pH
2 pO2
2 pCO2
2 pH 9 pCO2 R
2 Q2 MV RP
laverage 0.83 0.28 -0.18 – – – -0.18 0.88 0.70 0.93 0.79
lmax 0.67 0.32 -0.18 -0.19 -0.21 -0.22 -0.23 0.95 0.82 0.87 0.90
qglucose -0.85 – – -0.26 – – – 0.82 0.78 0.65 0.89
qlactate 0.93 – – – – – – 0.87 0.85 0.98 0.65
qp 0.58 0.34 -0.14 – – -0.31 -0.28 0.76 0.55 0.63 0.81
The coefficients according to the individual factors of the DoE are normalized. Coefficients that are shown
in italic are not considered as significant regarding the applied significance level
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significant models could be derived for nine amino acids
(Table 3). Hereby, higher pH values led to a higher con-
sumption of several amino acids (Ser, Asp, Val, Ile, Arg
and His). Similar effects were reported from Trummer
et al. [13]. Furthermore, significant effects of pO2 and
pCO2 on various amino acid consumption rates could be
derived indicating higher consumption rates at process
conditions that were favorable for cell growth (lmax, lav-
erage). To our knowledge, no effects of pO2 or pCO2 on
specific amino acid consumption or production rates in
CHO cells have been shown before in the literature. Seven
out of nine specific amino acid consumption or production
rates were significantly affected by process parameter
interactions; this demonstrates that interaction effects of
process parameters on cell physiology have to be
considered.
Amino acids could be divided into three groups. The
first group consisted of amino acids that were only con-
sumed throughout the batch processes (Arg, Val, Phe, Iso,
Leu, Pro, Asn, Ser, His, Tyr, Lys, Trp and Met), the second
contains amino acids that were only produced over process
time (Gly, Cys, Glu) and the last one consists of aspartate
and alanine, which were produced and/or consumed during
the batch processes (data not shown). In contrast to
Trummer et al. [13], aspartate was only produced at lower
pH values. Processes were not limited in any amino acid
before process harvest except of glutamine for processes at
pH 7.0 and 6.8 (Fig. 2b). Similar to effects reported from
Zagari et al. [29] and Wahrheit et al. [30] cells reacted to
glutamine limitation via uptake of alternative carbon
sources as lactate and aspartate, except processes at pH 7.0,
pCO2 20 %, pO2 25 % and pH 6.8, pCO2 20 % and pO2
10 % which showed no lactate consumption or very low
consumption after glutamine limitation (Fig. 2d).
The average specific IgG production rate qP was sig-
nificantly affected by process conditions, whereby lowest
rates were reduced to around 30 % when compared to the
maximum production rates obtained in this study.
The model data out of Table 2 indicates that pH strongly
affected specific productivity in a way that high pH set
points led to high qp values. Furthermore, quadratic effects
of pCO2, linear effects of pO2 and an interaction term of
pCO2 and pH were identified. Positive effects of pO2 on qp
are also reported in Link et al. [15], whereas Trummer et al.
[13] found no connections between pO2 and qp. Concerning
pCO2 Gray et al. [20] showed optimum levels around
76 mmHg, which is in agreement with our findings. No
effects of culture pH on qp could be shown in studies from
Trummer et al. [13] and Yoon et al. [25]. However, other
authors reported similar results, whereby qp increased with
increasing pH between pH 6.8 and 7.2 [31]. Contradictions
between the stated findings might derive from the different
cell lines used in these studies. Additionally, pH and pCO2
interaction effects similar to those already observed for
laverage and lmax could be detected for qp. To our knowl-
edge, no interaction effects of pH and pCO2 on cell specific
productivity have been reported so far in the literature. The
derived model showed similar coefficients to that one
obtained for lmax and laverage. This indicates that fermen-
tation conditions that induce high specific growth rates also
induce high specific production rates for this cell line.
Overall process titer of batch processes was mostly
dependent from the integral viable cell density similar to
Trummer et al. [13]. Therefore, highest final product con-
centrations could be derived at pH 7.0 and 6.8, whereas
space–time-yields were higher for processes at pH 7.0
(Fig. 3).
Effects on critical quality attributes (CQAs)
Size exclusion chromatography (SEC) for determination
of antibody size heterogeneity
During manufacturing and storage antibody size variants
(e.g., aggregates and fragments) occur. Since size
variants can influence immunogenicity, potency and
Table 3 Coefficient table and
summary of fit of the models
obtained for specific amino acid
production and consumption
rates
pH pO2 pCO2 pH
2 pCO2
2 pH 9 pCO2 pH 9 pO2 R
2 Q2 MV RP
qAsp -0.58 -0.2 -0.25 – 0.67 – – 0.96 0.82 0.91 0.91
qGlu – – -0.76 – 0.39 – – 0.76 0.69 0.90 0.66
qSer -0.45 – -0.47 -0.31 -0.22 0.26 – 0.82 0.58 0.90 0.67
qHis -0.36 -0.37 -0.13 -0.29 – 0.37 – 0.75 0.52 0.75 0.71
qArg -0.67 -0.59 -0.2 – -0.2 – 0.24 0.93 0.72 0.79 0.90
qGly -0.20 -0.58 0.37 – – – 0.42 0.81 0.63 0.52 0.89
qCys -0.31 -0.57 – – – – 0.49 0.78 0.70 0.77 0.78
qVal -0.58 – 0.12 – -0.49 0.32 – 0.94 0.61 0.57 0.95
qIle -0.44 – 0.20 – -0.31 0.47 – 0.77 0.51 0.33 0.92
qGly and qCys refer to specific amino acid production and all other amino acids to consumption rates. The
coefficients according to the individual factors of the DoE are normalized. Coefficients that are shown in
italic are not considered as significant regarding the applied significance level
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pharmacokinetics their levels are monitored during lot
release, stability and characterization [32].
Data out of SEC analysis show minor variations with
overall purity levels between 96 and 98 % relative Area
(data not shown). PLS models for sum of aggregates and
sum of fragments were conducted. No dependencies of
pCO2, pO2 or pH on antibody aggregation or fragmen-
tation were obtained from the gathered model data. Jing
et al. [33] observed a significant increase in protein
aggregation when changing dissolved oxygen from 50 to
15 % air saturation. Concerning pH, values far away
from the isoelectric point of the desired antibody
showed better protein solubility [34, 35, 36]. In contrast
to Gomes and Hiller [37], we could not detect any
changes in protein aggregation when varying culture
conditions in between the DoE settings. The mecha-
nisms leading to product aggregation may be strongly
product specific, explaining the differences between the
results in the literature.
Cation exchange chromatography (CEX) for determination
of antibody charge heterogeneity
Charge based antibody characterization is a frequently used
tool since it is sensitive to many type of modifications as
protein conformation, size, sequence species, glycosylation
and posttranslational modifications [11]. Therefore, various
antibody variations that occur with changing process con-
ditions were detected.
In total, we detected 18 different charge variants,
whereby significant models could be obtained for six
individual variants (i)–(vi) and one sum parameter (Fig. 4;
Table 4).
(i) The content of acidic charge variant 1 (deamidation
of asparagine to aspartate on one light chain) was signifi-
cantly influenced by culture pH (Table 4). Deamidation is
an unavoidable alteration reaction that takes place in fer-
mentation broth after secretion of the cell. Deamidation can
finally contribute to heterogeneity; affect protein crystal-
lization, stability and efficacy [38, 39]. Therefore, Liu et al.
[40] considered Asn deamidation as one of the most
important common modifications for mAbs. Deamidation
in our batch process data differed significantly, whereas at
pH 6.8 the highest protein deamidation could be observed
(Fig. 4). In contradiction to the literature, our studies would
suggest that lower pH values lead to higher deamidation
rates [41].
(ii) Considering acidic species 2 lower pH values led to
lower acidic variants (Fig. 4; Table 4). Additionally, a
Fig. 3 IgG concentration over process time (a) and integral viable
cell density (b) for all batch fermentations. (Black symbols represent
processes at pH 7.0, blue symbols at pH 6.8, red symbols at pH 7.2;
closed symbols represent processes at pCO2 5 %, half-closed at
12.5 % and open symbols at 20 %; triangles represent processes at
pO2 25 %, squares at 10 %, circles at 40 %). Highest process titers
were obtained for fermentation runs conducted at pH 7.0 and 6.8,
mainly due to the highest IVCD values at these process conditions
Fig. 4 Relative area out of cation exchange chromatography (CEX)
for various charge variants and one sum parameter at different pH set
points for pCO2 12.5 % and pO2 25 %
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significant interaction term for pH and pCO2 affecting
acidic variant 2 was identified.
(iii) Isomerization of Asp on one heavy chain, basic
charge variant 1, is congeneric to the deamidation reaction
leading to acidic charge variant 1. The isomerization
reaction occurs spontaneously in the culture media [38].
Data shows that pH had a significant effect on isomeriza-
tion whereby at lower pH values, higher amounts of iso-
merized variants occurred (Fig. 4; Table 4). These findings
are in agreement with the literature [42]. Analogous to Asn
deamidation, Asp isomerization is considered as one of the
most important common modifications for mAbs [40].
(iv, v) The presence of lysine residues on one heavy
chain, basic charge variant 2, was significantly affected by
culture pH (Fig. 4; Table 4). Moreover, the amount of
lysine residues on both heavy chains, basic charge variant
3, was also significantly affected by culture pH but with
opposite outcome (Fig. 4; Table 4). For charge variant 2,
lower culture pH led to lower amount of lysine residues
compared to runs at higher pH values. In contrast, models
obtained for charge variant 3 showed the opposite effect.
C-terminal lysine residues are a very common modification
observed during monoclonal antibody production. After
cell lysis, the release of basic carboxypeptidase is supposed
to be the reason for lysine heterogeneity, since no spon-
taneous reactions were found in other studies [39, 43–45].
Lower cell viabilities and prolonged process time at pH
6.8, therefore, should have led to a better cleavage of lysine
residues from the antibody. Interestingly, this is only the
case for lysine residue 2 whereas for charge variant 3 the
opposite effect is visible. C-terminal lysine residues are
considered as a rather less important mAb modification
[40].
(vi) The amount of basic charge variant 4 was signifi-
cantly influenced by process pH. The higher the pH value,
the lower the amount of basic charge variant 4 (Fig. 4;
Table 4). Moreover, a significant linear correlation with
pCO2 could be conducted out of the PLS model.
Glycosylation profile analysis for determination of N-
glycosylation heterogeneity
Proper glycosylation of mAbs is of upmost importance since
it can influence stability, effector functions, immunogenicity
and pharmacokinetics of the desired product [17]. 21 different
glycosylation patterns could be identified whereby the only
significant model concerning data from glycosylation analy-
sis could be obtained for glycosylation pattern bG1FSA_2
(di-N-acetylneuraminic acidylated, mono-galactosylated,
biantennary, fucosylated) (Table 4). Significant single effects
of process pH and an interaction term with pCO2 on glyco-
sylation variant bG1SA_2 were obtained. Analogous to
Zanghi et al. [19], these results would suggest a lower sialy-
lation at higher dissolved carbon dioxide and higher pH val-
ues. Around 75 % of the observed glycosylation profiles
consisted of bG0F (biantennary, fucosylated) and bG1F
(biantennary, mono-galactosylated, fucosylated) independent
from process conditions similar to Agarabi et al. [46] and as
reported by Raju et al. [47]. Furthermore, galactosylation,
sialylation and afucosylation level (GI, SI, aFI) variations
stayed in between narrow limits, mostly 25–30 % GI,
0.5–1.5 % SI and 4–8.0 % aFI, for all batch processes.
Moreover, GI, aFI and SI variation between center point runs
covered most glycosylation variations observed.
When plotting GI over SI and aFI, GI values correlate
positively with aFI and SI values (Fig. 5a linear determina-
tion coefficient R2 = 0.66; Fig. 5b linear determination
coefficient R2 = 0.36). This indicates that afucosylation,
sialylation and galactosylationwere all influenced likewise by
process conditions. Additionally, highest SI levels could be
observed mostly for pH values of 7.2. Furthermore, lowest SI
levels did not occur for high pO2 values at 40 %. Regarding
sialylation and process pH similar trends could be detected
from Ivarsson et al. [17]. Moreover, high sialylation corre-
lated with high Mannose 8 (Fig. 5c linear determination
coefficient R2 = 0.82) variants but not with Mannose 6
variants. Finally, highest amounts ofmannose 6 and 8 variants
Table 4 Coefficient table and summary of fit of the models obtained for the mAb charge variants and one glycan variant
pH pO2 pCO2 pH
2 pO2
2 pCO2
2 pH 9 pCO2 R
2 Q2 MV RP
(i) ACV 1 -0.44 – 0.37 0.24 – 0.28 -0.22 0.67 0.57 0.78 0.67
(ii) ACV 2 0.94 – -0.04 – – – -0.15 0.92 0.84 0.94 0.86
(iii) BCV 1 -0.65 0.13 0.17 – 0.27 0.29 – 0.87 0.72 0.59 0.90
(iv) BCV 2 0.74 – – -0.58 – – – 0.72 0.60 0.38 0.90
(v) BCV 3 -0.88 – – – – – – 0.77 0.73 0.68 0.85
(vi) BCV 4 -0.73 – 0.41 – – – – 0.78 0.71 0.78 0.81
sum of basic variants -0.64 0.19 0.17 – 0.22 0.3 – 0.82 0.59 0.64 0.84
bG1FSA_2 -0.03 – -0.26 0.67 – – -0.48 0.76 0.53 0.84 0.68
The coefficients according to the individual factors of the DoE are normalized. Coefficients that are shown in italic are not considered as
significant regarding the applied significance. Acidic charge variants (ACV), basic charge variants (BCV) and one glycan variant are presented
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could only be observed for pH values at 6.8 and 7.2 (Fig. 5d).
A huge amount of process variables affecting protein glyco-
sylation in mammalian cells have been reported as substrate
concentrations, media composition, by-product accumula-
tion, temperature, cell viability and shear stress [48]. Litera-
ture about the influence of process parameters on mAb
glycosylation are partly contradicting and seem to be strongly
dependent on the specific cell line, product and cultivation
conditions. Concerning pO2 variations different results are
reported but consistent glycosylation profiles can be expected
for DO between 10 and 100 % [48]. Ivarsson et al. [17] stated
a slight increased protein galactosylation and sialylation at
low DO 10 % and high DO 90 % compared to 50 % DO.
Studies about the influence of pCO2 on glycosylation are less
represented. Nevertheless, Zanghi et al. [19] and Kimura and
Miller [49] showed decreased polysialylation and N-gly-
colylneuraminic acid (NGNA) when increasing pCO2.
Trummer et al. [13] reported no effect on EPO-FC sialylation
when varyingDO between 10 and 100 % and pH between 6.8
and 7.3. In contrast, Ivarsson et al. [17] recently showed that
galactosylation and sialylation levels slightly increased when
pH increased between 6.8 and 7.2.
Finally, through our applied control strategy and
experimental design, we could not only detect independent
single process parameter effects on cell physiology and
product quality but also furthermore derive several new
process parameters interaction effects. A short summary of
several key responses affected by process parameter
interactions is given in Table 5.
Conclusions
The goal of this contribution was to assess the interactions
of scale dependent process parameters and their indepen-
dent effects in a multivariate manner. Only, the decoupled
Fig. 5 Correlations and trends of glycosylation variants. (Black
symbols represent processes at pH 7.0, blue symbols at pH 6.8, red
symbols at pH 7.2; closed symbols represent processes at pCO2 5 %,
half-closed at 12.5 % and open symbols at 20 %; triangles represent
processes at pO2 25 %, squares at 10 %, circles at 40 %). Antibody
galactosylation level (GI) over a sialylation (SI) and b afucosylation
(aFI). Antibody galactosylation seemed to correlate positively with
afucosylation and sialylation. A strong correlation between sialylation
and mannosylation 8 were derived from C. In D, mannose 8 levels are
plotted over mannose 6, it can be derived that highest mannosylation
levels only occurred for processes at pH 6.8 and 7.2
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control of process pH, pO2 and pCO2, allowed us to exe-
cute a design of experiments to investigate the interactions
and independent influences of these parameters on CHO
cell physiology, process performance and critical product
quality attributes.
Concerning cell specific growth, glucose consumption,
lactate production, amino acid metabolism and specific
productivity process pH seemed to provoke the strongest
effects. Variations of pO2 and pCO2 exerted influence on
cell growth as well as on specific productivity, whereby we
found a positive correlation for dissolved oxygen and
mostly quadratic interactions for pCO2 with an optimum at
around 10 % (90 mmHg). Amino acid metabolism was
mainly affected by pH, but the gathered data revealed
additional interactions and single effects of pO2 and pCO2.
Besides process performance, final product quality is of
upmost importance for pharmaceutical bioprocesses.
Therefore, critical quality attributes (CQAs), such as
charge and size heterogeneity as well as N-glycosylation
pattern were investigated. Concerning mAb aggregation
and fragmentation no correlations with process pH, pO2 or
pCO2 could be obtained. Significant correlations between
process pH or pCO2 with mAb charge modifications as
asparagine deamidation and aspartate isomerization could
be derived from data out of cation exchange chromatog-
raphy. The effect of process parameters on N-glycosylation
heterogeneity is reported contradictorily in the literature
and seems to be strongly dependent from the specific cell
line, product and further cultivation conditions. In our
study, positive correlations between antibody galactosyla-
tion, afucosylation and sialylation were found. Further-
more, highest sialylation levels could mostly be detected at
pH 7.2 and highest mannose variants (Man8 and Man6)
could only be observed at two distinct pH set points.
In the end, novel interactions that could be derived are
pH and pCO2 interaction effects on specific cell growth
(lmax, laverage) and specific productivity (qP). Moreover,
several interaction effects of pO2 and pCO2 with pH on
amino acid metabolism, as well as pCO2 and pH interac-
tions on mAb charge variants and N-glycosylation variants
were identified.
The presented results demonstrate the necessity to
consider process parameter interactions on cell physiology,
overall process performance and product quality. In large-
scale processes, heterogeneities and gradients of process
pH, pO2 and pCO2 can occur, exposing cells dynamically
to changing environments. Therefore, not only the single
parameter influences but also their interaction effects vary
inside of large-scale processes. Especially process pH and
pCO2 are usually coupled in cell culture processes,
whereby zones with high pH, as they can appear due to
base addition from top, simultaneously lead to low pCO2
values, whereas pCO2 accumulation can lead to zones with
lower pH values, respectively. Based on our results, pH
variations that might occur due to CO2 accumulation or
base addition in large-scale are most probably the dominant
factor concerning process parameter induced scale-up
effects. CO2 accumulation in large-scale can furthermore
reduce specific cell growth, specific productivity and affect
amino acid metabolism. In our experiments, pO2 had the
lowest effects on cell physiology and product quality.
Therefore, temporary pO2 gradients that might occur in
large-scale most probably only exert minor effects on
process performance and CQAs. Based on the results of
Table 5 Summary table of key responses affected by process parameter interactions as well as the observed single parameter effects and
literature comparison
Observed single parameter effects Process
parameter
interactions
Literature
laverage Higher at increased pH, and pO2; quadratic pCO2 effects pH 9 pCO2 Similar single effects
[13, 15, 18, 25]
qp Higher at increased pH, and pO2; quadratic pCO2 effects pH 9 pCO2 Similar single effects [15, 20];
Contrary single effects [13, 25]
qAA Higher uptake rates and lower production rates of several amino
acids at increased pH and pO2; contrary effects of pCO2
pH 9 pCO2/
pH 9 pO2
Similar single effects of process
pH [13]
mAb acidic charge
variant (ACV 2)
Higher at increased process pH pH 9 pCO2 No literature available since
variant identity is unknown
mAb sialylation
(bG1FSA_2)
Quadratic pH effects pH 9 pCO2 Similar interaction effect [19]
Key responses with process parameter interaction effects: average specific cell growth (laverage), specific productivity (qp), specific amino acid
consumption/production rates (qAA), acidic charge variant 2 and mAb sialylation variant bG1FSA_2. Effects are only valid inside of the
experimental design space. Contradictions to/in literature may derive from cell line specific effects. More detailed information is presented in the
corresponding paragraphs of the ‘‘Results and discussion’’ section
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this study the consideration of process parameter interac-
tions is recommended for mechanistic and hybrid modeling
approaches as well as scale-up tasks.
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